Lange PH - Search Results

1

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study.

Higano CS, Ellis W, Russell K, Lange PH. Higano CS, et al. Among authors: lange ph. Urology. 1996 Nov;48(5):800-4. doi: 10.1016/S0090-4295(96)00381-0. Urology. 1996. PMID: 8911533 Clinical Trial.

2

Prostate cancer.

Ellis WJ, Lange PH. Ellis WJ, et al. Among authors: lange ph. Endocrinol Metab Clin North Am. 1994 Dec;23(4):809-24. Endocrinol Metab Clin North Am. 1994. PMID: 7705321 Review.

3

Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.

Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG. Ellis WJ, et al. Among authors: lange ph. Urology. 1997 Oct;50(4):573-9. doi: 10.1016/S0090-4295(97)00251-3. Urology. 1997. PMID: 9338734 Clinical Trial.

4

The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.

Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin MM, Melchior S, Lange PH. Ellis WJ, et al. Among authors: lange ph. J Urol. 1998 Apr;159(4):1134-8. J Urol. 1998. PMID: 9507816

5

Serum percent free prostate-specific antigen in metastatic prostate cancer.

Lin DW, Noteboom JL, Blumenstein BA, Ellis WJ, Lange PH, Vessella RL. Lin DW, et al. Among authors: lange ph. Urology. 1998 Sep;52(3):366-71. doi: 10.1016/s0090-4295(98)00240-4. Urology. 1998. PMID: 9730445

6

Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model.

Buhler KR, Santucci RA, Royai RA, Whitney SC, Vessella RL, Lange PH, Ellis WJ. Buhler KR, et al. Among authors: lange ph. Prostate. 2000 Apr 1;43(1):63-70. doi: 10.1002/(sici)1097-0045(20000401)43:1<63::aid-pros9>3.0.co;2-d. Prostate. 2000. PMID: 10725867

7

Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH. Ellis WJ, et al. Among authors: lange ph. Clin Cancer Res. 1996 Jun;2(6):1039-48. Clin Cancer Res. 1996. PMID: 9816265

8

Analysis and sorting of prostate cancer cell types by flow cytometry.

Liu AY, True LD, LaTray L, Ellis WJ, Vessella RL, Lange PH, Higano CS, Hood L, van den Engh G. Liu AY, et al. Among authors: lange ph. Prostate. 1999 Aug 1;40(3):192-9. doi: 10.1002/(sici)1097-0045(19990801)40:3<192::aid-pros7>3.0.co;2-f. Prostate. 1999. PMID: 10398281

9

Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.

McNeel DG, Nguyen LD, Ellis WJ, Higano CS, Lange PH, Disis ML. McNeel DG, et al. Among authors: lange ph. Prostate. 2001 May 15;47(3):222-9. doi: 10.1002/pros.1066. Prostate. 2001. PMID: 11351352

10

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration.

Bladou F, Vessella RL, Buhler KR, Ellis WJ, True LD, Lange PH. Bladou F, et al. Among authors: lange ph. Int J Cancer. 1996 Sep 17;67(6):785-90. doi: 10.1002/(SICI)1097-0215(19960917)67:6<785::AID-IJC6>3.0.CO;2-N. Int J Cancer. 1996. PMID: 8824549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters